Arista Biologicals
Arista Biologicals is a US-based manufacturer of rapid diagnostic reagents specializing in lateral flow assay (LFA) technology for infectious disease detection, most notably a West Nile Virus LFA. It serves IVD manufacturers and research institutions as a subsidiary brand within the Fortis Life Sciences portfolio.
- Company typePrivate
- Founded1993
- HeadquartersAllentown, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Arista Biologicals does
Arista Biologicals is a US-based manufacturer and supplier of rapid diagnostic reagents, founded in 1993 and headquartered in Allentown, Pennsylvania. The company specializes in Lateral Flow Assay (LFA) technology applied to infectious disease detection, with its featured commercial product being a West Nile Virus LFA. The underlying technology is a lateral flow immunoassay platform, in which biological samples migrate across a membrane to produce a visible signal indicating the presence of a target pathogen; this is a well-established, low-cost, point-of-care diagnostic format. Arista's product portfolio positions it as a specialized supplier of validated detection reagents and diagnostic components rather than a finished-test marketer, targeting in vitro diagnostic (IVD) manufacturers developing rapid infectious disease tests as the primary customer segment, with secondary demand from academic and research laboratories.
Commercially, Arista operates exclusively as a subsidiary brand within the Fortis Life Sciences portfolio (Fortis Life Science, LLC), which integrates multiple specialized reagent and diagnostics companies spanning antibodies, ELISA kits, enzymes, engineered nanoparticles, VHH antibody libraries, and viral vector platforms. Arista contributes lateral flow assay expertise, particularly for arboviral targets, and benefits from Fortis's distribution network of 26 active locations across North America, South America, Europe, Asia, Africa, and Oceania, supported by regional sales representatives and authorized distributors. The business model is quote-based product and component sales to enterprise IVD customers and research institutions, with no publicly disclosed pricing. Three of the Fortis network's manufacturing sites are reported as ISO 13485 certified and GMP compliant, which is a relevant quality system signal for diagnostic-grade reagent supply, though Arista-specific certifications were not enumerated. The company has a small employee base (11-50) and no independent funding history, M&A activity, or product launch cadence is disclosed in the source data.
Arista Biologicals firmographics
Firmographics- Name
- Arista Biologicals
- Legal name
- Arista Biologicals
- Website
- https://aristabiologicals.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Arista Biologicals is a US-based manufacturer of rapid diagnostic reagents specializing in lateral flow assay (LFA) technology for infectious disease detection, most notably a West Nile Virus LFA. It serves IVD manufacturers and research institutions as a subsidiary brand within the Fortis Life Sciences portfolio.
- Ownership category
- akta.pro rank
Arista Biologicals industry classification
Industry- Product category
- In Vitro Diagnostics (Lateral Flow Assay Reagents)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industry
- Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)
Keywords
Where Arista Biologicals is headquartered
LocationHeadquarters
- HQ city
- Allentown
- HQ country
- United States
- HQ region
- North America
Markets served
Arista Biologicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Lateral Flow Reagent Products: Sale of lateral flow assay reagents and components for infectious disease diagnostics
- Diagnostic Components: Supply of diagnostic components for IVD manufacturers
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Arista Biologicals product offering
Product offeringCore offering
Arista Biologicals manufactures and supplies rapid diagnostic reagents and components based on lateral flow assay (LFA) technology for infectious disease detection. Its flagship offering is a West Nile Virus LFA product, sold to in vitro diagnostic (IVD) manufacturers and research institutions. The company operates as a specialized diagnostics brand within the Fortis Life Sciences portfolio, with manufacturing at ISO 13485 certified and GMP compliant sites.
Product overview
Arista Biologicals is a partner brand within the Fortis Life Sciences portfolio, offering specialized lateral flow assay products. The company provides the West Nile Virus LFA (Lateral Flow Assay) product as part of the lateral flow reagents category, which also includes antibodies and antigens for diagnostic applications. Arista Biologicals operates as part of a unified platform spanning antibodies, diagnostic components, molecular biology reagents, engineered nanoparticles, and viral vector platforms under the Fortis Life Sciences umbrella.
Differentiator
Problem solved
Functional benefit
Products and services
- Arista Biologicals West Nile Virus LFA
Companies that use Arista Biologicals
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Arista Biologicals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Arista Biologicals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fortis Life SciencescoreArista Biologicals is part of the Fortis Life Sciences portfolio of specialized companies. Fortis Life Sciences integrates companies spanning antibodies, diagnostic components, molecular biology reagents, engineered nanoparticles, and viral vector platforms. Arista contributes lateral flow assay expertise for infectious disease diagnostics to the broader Fortis ecosystem.
Scale indicators2 records
Recent moves3 records
Expansion highlights3 records
Arista Biologicals competitors and assessment
Company assessmentBroad incumbents
- Abcam: Abcam (now part of Danaher) is a leading supplier of research-grade antibodies and immunoassay reagents to life science researchers and diagnostics developers — a comparable broader reagent supplier operating in Fortis' core customer ecosystem.
- Meridian Bioscience: Meridian (now part of Revvity/Sartorius-affiliated portfolio) manufactures a broad range of IVD reagents and rapid tests across infectious disease and gastrointestinal panels — comparable as a larger incumbent in the same IVD reagent and rapid test space.
- Bio-Rad Laboratories: Bio-Rad manufactures a broad portfolio of life science reagents, immunoassay kits, and quality controls used in clinical diagnostics and research — comparable as a larger reagent manufacturer that competes with Arista/Fortis in supplying IVD developers and research labs.
- QuidelOrtho: QuidelOrtho is a major diagnostics manufacturer offering rapid immunoassays, lateral flow tests, and molecular diagnostics across infectious disease and women's health — comparable as a broader incumbent with overlapping LFA capabilities and IVD manufacturer customers.
Direct peers
- OraSure Technologies: OraSure develops and markets rapid diagnostic tests and sample collection devices for infectious diseases including HIV and HCV — comparable as a rapid diagnostics specialist with overlapping infectious disease focus and OEM/custom-manufacturing capabilities.
- InBios International: InBios develops and manufactures rapid immunochromatographic (lateral flow) diagnostic tests for infectious diseases including arboviruses such as West Nile, Dengue, and Zika — directly comparable to Arista's core LFA reagent and assay focus.
- CTK Biotech: CTK Biotech manufactures rapid lateral flow diagnostic tests for infectious diseases including malaria, dengue, and other tropical pathogens — comparable in product format and customer base to Arista's infectious disease LFA portfolio.
- Chembio Diagnostics: Chembio specializes in lateral flow rapid diagnostic tests for infectious diseases including HIV, syphilis, and febrile illness panels — a direct peer in LFA infectious disease diagnostics serving similar OEM and clinical lab customers.
Emerging players
- GenScript Biotech: GenScript manufactures custom antibodies, recombinant proteins, and IVD reagent components for diagnostics developers — comparable as an emerging player offering overlapping reagent inputs to the same IVD manufacturer customer base.
- Hememics Biotechnologies: Hememics develops rapid, point-of-care biosensor-based diagnostics including lateral-flow formats for infectious disease — a smaller emerging player with overlapping rapid diagnostic technology and customer focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights2 records
Customer concentration
Arista Biologicals social profiles
Digital presenceArista Biologicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arista Biologicals leadership team
Management profileNumber of profiles
Arista Biologicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arista Biologicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arista Biologicals
What does Arista Biologicals do?
Arista Biologicals manufactures and supplies rapid diagnostic reagents and components based on lateral flow assay (LFA) technology for infectious disease detection. Its flagship offering is a West Nile Virus LFA product, sold to in vitro diagnostic (IVD) manufacturers and research institutions. The company operates as a specialized diagnostics brand within the Fortis Life Sciences portfolio, with manufacturing at ISO 13485 certified and GMP compliant sites.
When was Arista Biologicals founded?
Arista Biologicals was founded in 1993. It employs 11 to 50 people.
Where is Arista Biologicals based?
Arista Biologicals is headquartered in Allentown, United States, in the North America region.
How does Arista Biologicals make money?
Two revenue lines are on record. Lateral Flow Reagent Products are the primary driver. The others are diagnostic Components.
Who are Arista Biologicals's main competitors?
Broad incumbents on record are Abcam, Meridian Bioscience, Bio-Rad Laboratories and QuidelOrtho. Direct peers are OraSure Technologies, InBios International, CTK Biotech and Chembio Diagnostics. Emerging players are GenScript Biotech and Hememics Biotechnologies.
Does Arista Biologicals have an API?
No public API is recorded for Arista Biologicals.
What industry is Arista Biologicals in?
Arista Biologicals's product category is In Vitro Diagnostics (Lateral Flow Assay Reagents). Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAALAN, Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays. Its NAICS code is 325413 and its SIC code is 2835.